» a2-Antiplasmin Immunodepleted Deficient Human Plasma

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

a2-Antiplasmin Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Immunodepleted Deficient Human Plasma for α2-Antiplasmine assay.

Pool of normal citrated plasmas depleted in α2-antiplasmin (α₂AP) by anti-α₂AP antibodies grafted on agarose gel. Contains 20 mM Hepes buffer.

Reference	6-FDPA2AP
Presentation	Bottle
Format	1 x 100 mL
Quote

Reference	6-FDPA2AP-10
Presentation	Kit
Format	10 x 1.0 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
6-FDPA2AP	Bottle	1 x 100 mL
6-FDPA2AP-10	Kit	10 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

α2-antiplasmin (α-2-antiplasmin or α-2-AP) is the main inhibitor of plasmin, the key enzyme in fibrinolysis.
It binds to FXIII and to fibrin, allowing the stabilization of the thrombus.

Packaging in plastic cryotubes or in bottles of at least 100 mL.

Frozen, immuno-depleted plasmas are certified to have less than 1% for the deficient factor considered, both for the antigenic and functional assay in haemostasis.
This box is intended for research use.

- No bovine additives.
- No reconstitution error.
- No plasma alteration linked to freeze-drying.
- Cryotubes ready to use after thawing (4 min at 37°C).

- 10 cryotubes x 1 mL or 100 mL vial of frozen plasma.

Antithrombin deficient plasma immuno depleted
Factor IX immuno depleted deficient plasma
Factor V immuno depleted deficient plasma
Plasma Factor VII deficient immuno depleted
Plasma Factor VIII deficient chemically depleted
Plasma Factor X deficient immuno depleted
Plasma Factor XI deficient immuno depleted
Plasma Factor XII deficient immuno depleted
Prothrombin deficient plasma immuno depleted

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS